CHRONIC HEPATITIS B
Clinical trials for CHRONIC HEPATITIS B explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hepatitis b drug trial halted early
Disease control TerminatedThis early-stage study tested a new medicine called RO7565020 in healthy people and those with chronic hepatitis B. The goal was to check safety and how the drug moves through the body. The trial was stopped early, so results are limited.
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 04:34 UTC
-
Can antibody shots cure hepatitis b? early trial halted
Disease control TerminatedThis study tested whether giving hepatitis B antibodies (HBIG) could clear the hepatitis B surface antigen (HBsAg) from the blood of people with chronic hepatitis B. The trial aimed to enroll 20 adults who had the infection for at least a year and were already on antiviral medica…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE2 • Sponsor: Hannover Medical School • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
Experimental hepatitis b drug shows promise in early trial
Disease control TerminatedThis study tested an experimental drug called ARC-520, given alongside standard hepatitis B medications (entecavir or tenofovir), in people with chronic hepatitis B. The goal was to see if it could lower the amount of hepatitis B surface antigen in the blood. Only 4 people took p…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC